share_log

邁博藥業-B:(1) 有關收購CMAB807之須予披露及關連交易 (2) 有關臨床試驗協議及CDMO協議之持續關連交易 及 (3) 變更所得款項用途

MABPHARM-B: (1) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF CMAB807 (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE CLINICAL TRIALS AGREEMENT AND THE CDMO AGREEMENT AND (3) CHANGE IN USE OF PROCEEDS

Mar 1, 2021 09:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more